|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.18 USD | +4.39% |
|
+4.58% | -30.26% |
| 07-30 | Core Laboratories Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-29 | Core Laboratories Inc. Provides Earnings Guidance for the Third Quarter of 2026 | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 26.12x | - | -0.66x | - | - | - | 0.37% | 491M | ||
| 26.11x | 14.16x | 3.47x | 2.91x | 13.05x | 18.21x | 3.28% | 23.65B | ||
| 43.1x | 11.49x | 1.35x | 5.68x | 20.93x | 28x | 0.64% | 18.35B | ||
| 20.39x | 2.77x | 1.39x | 2.92x | 12.02x | 17.17x | 1.3% | 3.52B | ||
| 13.19x | 1.73x | 2x | - | - | - | 2.48% | 2.21B | ||
| -35.64x | 0.8x | 0.56x | 1.31x | 8.43x | 39.82x | -.--% | 1.74B | ||
| 21.83x | 2.74x | 4.88x | - | - | - | 2.34% | 1.58B | ||
| 34.44x | 2.02x | 2.47x | - | - | - | - | 656M | ||
| 17.93x | 2.81x | -24.05x | - | - | - | - | 598M | ||
| 35.95x | 1.34x | -0.25x | - | - | - | - | 581M | ||
| Average | 20.34x | 4.43x | -0.89x | 3.21x | 13.61x | 25.80x | 1.49% | 5.34B | |
| Weighted average by Cap. | 29.01x | 10.76x | 2.09x | 3.93x | 15.86x | 22.73x | 2% |
- Stock Market
- Stocks
- CLB Stock
- Sector Core Laboratories Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















